Efficacy of Ocrelizumab vs Interferon/Glatiramer Acetate in People With MS Older Than 60 Years
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Neurology, Neurosurgery, and Psychiatry
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparing ocrelizumab to interferon/glatiramer acetate in people with multiple sclerosis over age 60
J. Neurol. Neurosurg. Psychiatr. 2024 Mar 07;[EPub Ahead of Print], YC Foong, D Merlo, M Gresle, K Buzzard, M Zhong, WZ Yeh, V Jokubaitis, M Monif, O Skibina, S Ozakbas, F Patti, P Grammond, MP Amato, T Kalincik, D Horakova, E Kubala Havrdova, B Weinstock-Guttman, J Lechner Scott, C Boz, MJ Sa, H Butzkueven, A van der Walt, C ZhuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.